Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?
| dc.contributor.author | Benbaba, S | * |
| dc.contributor.author | Isaakidis, P | * |
| dc.contributor.author | Das, M | * |
| dc.contributor.author | Jadhav, S | * |
| dc.contributor.author | Reid, T | * |
| dc.contributor.author | Furin, J | * |
| dc.date.accessioned | 2015-12-30T21:30:06Z | en |
| dc.date.available | 2015-12-30T21:30:06Z | en |
| dc.date.issued | 2015-12-29 | en |
| dc.identifier.citation | Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?, 10 (12):e0144936 PLoS ONE | en |
| dc.identifier.issn | 1932-6203 | en |
| dc.identifier.pmid | 26713873 | en |
| dc.identifier.doi | 10.1371/journal.pone.0144936 | en |
| dc.identifier.uri | http://hdl.handle.net/10144/592662 | en |
| dc.description.abstract | Directly-observed therapy (DOT) is recommended for drug-resistant tuberculosis (DR-TB) patients during their entire treatment duration. However, there is limited published evidence on implementation of direct observation (DO) in the field. This study aims to detail whether DO was followed with DR-TB patients in a Médecins Sans Frontières (MSF) tuberculosis program in Mumbai, India. | |
| dc.language | ENG | en |
| dc.language.iso | en | en |
| dc.rights | Published by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permission | en |
| dc.title | Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO? | en |
| dc.identifier.journal | PloS One | en |
| refterms.dateFOA | 2019-03-04T12:39:21Z | |
| html.description.abstract | Directly-observed therapy (DOT) is recommended for drug-resistant tuberculosis (DR-TB) patients during their entire treatment duration. However, there is limited published evidence on implementation of direct observation (DO) in the field. This study aims to detail whether DO was followed with DR-TB patients in a Médecins Sans Frontières (MSF) tuberculosis program in Mumbai, India. |
